openPR Logo
Press release

Non-Small Cell Lung Cancer Market - Size, Share, Growth and Trends Analysis 2018–2026

06-25-2018 03:42 PM CET | Health & Medicine

Press release from: CMI Research

Non-Small Cell Lung Cancer Market - Size, Share, Growth

Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer Alliance (leading nonprofit organization dedicated to fighting lung cancer), out of overall lung cancer, around 80 to 85% cases found are of non-small cell lung cancer type and 15-20% cases found are of small cell lung cancer type.

Access Full Summary at: https://www.coherentmarketinsights.com/ongoing-insight/non-small-cell-lung-cancer-market-241

The different, commonly diagnosed types of non-small cell lung cancer (NSCLC) are adenocarcinoma, squamous cell carcinoma, large cell carcinoma, large cell neuroendocrine tumors. Out of all these types adenocarcinoma and squamous cell carcinoma accounts around 60% of lung cancer.

There are no exact reason defined till yet by doctors behind lung cancer but some possible reasons are smoking, air pollution, mineral and metal dust, radiation treatment of chest or breast. The lung cancer symptoms are not noticeable in its early stage because they are considered for other type of illness for example pneumonia or collapsed lung. Some symptoms of lung cancer are chest pain, harsh/raspy sound during breathing, wheezing, weight loss, continuous coughing, hoarseness or voice changes, shortness of breath, lung problems like bronchitis or pneumonia etc. might be the symptoms of lung cancer. Also, if it spreads in other parts of the body then it shows symptoms like bone pain, weakness in arm or leg, yellow skin, yellow eyes, headache and balance problems.

Some diagnosis test are performed by doctors to detect the lung cancer includes diagnostic imaging test like X-ray, MRI, Ultrasound, CT scan and PET scan, also by checking the mucous when the patient cough up for cancer cells which is called as sputum cytology or also by taking the cells of your lungs from abnormal growth area of your lung or from the fluid of lungs which is called as fine needle aspiration biopsy, bronchoscopy and Mediastinoscopy.

Request to Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/241

Increasing research and development on drugs and the prevalence of lung cancer are the major factors driving the growth of non-small cell lung cancer market

Therefore, U.S. holds the largest market share of non-small cell lung cancer market followed by Europe as the large number of smokers are present in this region but in last few years the APAC region showed increased number of smokers. According to the stats of International Association for the Study of Lung Cancer (IASLC), China is the world’s largest consumer of tobacco having around 301 million smokers. While in western region the growth in number of smokers. According to the data published by World Health Organization (WHO), for the year 2012 there were around 58% of cases occurred in less developed regions.

Some are the leading companies in non-small cell lung cancer are AstraZeneca Plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Agennix AG, ArQule Inc, GlaxoSmithKline Pharmaceuticals Limited, Daiichi Sankyo Co. Ltd., Sanofi-Aventis, and Boehringer Ingelheim GmbH. Also as per U.S. Food and Drug Administration some latest drug approvals in Market of non-small cell lung cancer by USFDA are on October 24, 2016 pembrolizumab (Merck & Co., Inc.) received approval, also FDA approved atezolizumab for the treatment of NSCLC on October 18, 2016.

Non-small cell lung cancer market (NSCLC) taxonomy:

Global NSCLC Market by Type of NSCLC: Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma, Large cell neuroendocrine tumors

Global NSCLC Market by Type of Treatment: Surgery, Chemotherapy, Targeted therapy, Radiation therapy,.

Global NSCLC Market by Geography: North America, Europe, APAC, Latin America, Middle East, Africa,.

Request for Table of Contents @ https://www.coherentmarketinsights.com/ongoing-insight/toc/241

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Small Cell Lung Cancer Market - Size, Share, Growth and Trends Analysis 2018–2026 here

News-ID: 1096843 • Views: 447

More Releases from CMI Research

Wearable Patch Industry Adoption of Innovative Offerings and Forecast 2019-2027
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Wearable Patch Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the
Hemodialysis Industry Showcase Attractive Growth Opportunities and Forecast 2019 …
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Hemodialysis Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the global
Breast Reconstruction Industry Positive Long-Term Growth Outlook and Forecast 20 …
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Breast Reconstruction Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the
Elderly Nutrition Industry Emerging Growth, Trend and Forecast to 2027
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Elderly Nutrition Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the

All 5 Releases


More Releases for NSCLC

Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Size, Status and Forec …
Market Research Report Store offers a latest published report on Targeted Drug EGFR RTK Inhibitors for NSCLC Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/624297/global-targeted-drug-egfr-rtk-inhibitors   In 2018,
Targeted Drugs for NSCLC Market Size by 2025: QY Research
Global Targeted Drugs for NSCLC market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. This report covers five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data. Apart from this, the report also covers detail
"NSCLC - Market Outlook and Competitive Landscape Report 2015 – 2030 "
Report Snapshot: NSCLC is the most common form of lung cancer, accounting for approximately 85% of all types and subtypes of lung cancer. It grows and spreads more slowly than small cell lung cancer. Early stage disease is associated with uncommon specific symptoms; hence roughly ~50% to 73% of cases are not being diagnosed until the disease is at an advanced stage when the chances for cure or significant patient benefit
Non-Small Cell Lung Cancer (Nsclc)-China Drug Forecast and Market Analysis To 20 …
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast And Marke …
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva
The NSCLC Market Will Be Valued At $10.9 Billion In 2021 At A CAGR Of 8.5%
Researchmoz added Most up-to-date research on "Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line" to its huge collection of research reports. Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a poor outlook, particularly for patients with advanced disease, has created a pressing need